In vitro data from rigorously controlled assays in Fisher rat thyroid (FRT) cells expressing rare CFTR mutations has become an important step in meeting regulatory requirements for approval of drugs that could help individuals with CF-causing gating mutations not addressed in clinical trials [60]. The gene discussed is CFTR; the disease is cystic fibrosis.